|
|
|
|
||
Little discussion of Afrezza in Sanofi's Cowen presentation. In the posted pdf version of the Sanofi's presentation slides, there is no discussion of Afrezza. In the oral presentation Afrezza was a short mention of Afrezza and an additional option for patients. Little in the way of specifics except noted demand from physicians and is quite different from Exubera. More emphasis, it seemed on Toujeo, Lyxumia and LixiLan. Maybe there will be questions about the launch from analysts. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
8864 | Re: Little discussion of Afrezza in Sanofi's Cowen presentation. | eagle76 | 0 | 3/4/2015 12:05:26 PM |
8865 | Re: Little discussion of Afrezza in Sanofi's Cowen presentation. | oldfishtowner | 0 | 3/4/2015 12:10:42 PM |